摘要
目的 :在取消医保定点零售药店资格审查的趋势下,为我国连锁药店未来规模化发展提供参考意见。方法:描述分析法提出我国连锁药店存在低集中度和低连锁化等问题以及新政策带来的影响;利用波特五力模型,分析我国零售药店面临新的竞争环境,包括DTC、DTP的兴起以及上下游环节面临的挑战。结果及结论 :新形势下,我国连锁药店企业应当通过并购、提供医疗服务、获取独家代理、加强供应链管理等途径提高核心竞争力,来应对外部竞争环境。
Objective： To provide a reference for the scale development of chain drugstores in the future in China under the trend of canceling the medical insurance fixed-point approval. Methods： The existing problems such as low concentration and low chaining in Chinese chain drugstores and the effects of new policy on them were proposed by description method and the new competitive environment to be facing by retail pharmacies in China was analyzed by porter＇s five model including the rise of DTC and DTP＇s as well as the challenge to be facing by the upstream and downstream sectors. Results ＆ Conclusion： The Chinese enterprises working on the management of chain drugstore should improve their core competitiveness by mergers and acquisitions, providing medical services, getting an exclusive agent and strengthening the management of supply chain so as to deal with the external competitive environment.
出处
《上海医药》
CAS
2016年第3期61-64,共4页
Shanghai Medical & Pharmaceutical Journal
关键词
连锁药店
医保定点审批
医疗服务
chain drugstores
medical insurance fixed-point approval
medical services
